{
    "clinical_study": {
        "@rank": "80686", 
        "acronym": "OXYASD", 
        "arm_group": [
            {
                "arm_group_label": "OCYTOCINA - SPRAY NASAL", 
                "arm_group_type": "Active Comparator", 
                "description": "OCYTOCINA - SPRAY NASAL - 24Ui twice per day for 8 weeks"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo - twice per day for 8 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is design to evaluate the influence of oxytocin in some aspects of Autism\n      Spectrum Disorder (ASD), such as, repetitive and stereotyped behavior, social skills,\n      quality of life and disruptive behaviors.\n\n      Null hypothesis: social skills, quality of life, disruptive behaviors and repetitive\n      behaviors do not improve with the use of oxytocin. Experimental Hypothesis: social skills,\n      quality of life, disruptive behaviors and repetitive and stereotyped behaviors improve with\n      the use of oxytocin."
        }, 
        "brief_title": "Oxytocin in Adolescents With Autism Spectrum Disorders", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Autism Spectrum Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Autistic Disorder", 
                "Child Development Disorders, Pervasive"
            ]
        }, 
        "detailed_description": {
            "textblock": "Individuals with ASD have impaired social interaction, repetitive and disruptive behaviors.\n      Oxytocin has been described to improve those skills and studies suggest that administration\n      can reduce repetitive  behaviors as well as enhance social interaction and communication\n      deficits.\n\n      This study is design to evaluate the influence of oxytocin in some aspects of Autism\n      Spectrum Disorder (ASD), such as, repetitive and stereotyped behavior, social skills,\n      quality of life and disruptive behaviors.\n\n      Instruments:\n\n        1. Evaluation of social skills: Matson Evaluation of Social Skills (MESSY): consisting of\n           62 items divided into six factors that assess social skills such as appropriate social\n           skills, assertiveness inadequate, impulsivity, self-confidence, jealousy withdraw, and\n           other items that do not fit another classification.\n\n        2. Evaluation of repetitive behavior: Repetitive Behavior Scale (RBS): Consists of 43\n           items divided into six subscales: stereotyped behavior, self-harm behavior, compulsive\n           behavior, ritualistic behavior, behavior monotonous and restricted behavior. This scale\n           is able to measure the presence and severity of repetitive behaviors as common in\n           individuals on the autism spectrum.\n\n        3. Evaluation disruptive behavior: Vineland, just the part that assess disruptive behavior\n\n        4. Multidimensional Student's Life Satisfaction Scale (MSLSS)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male\n\n          -  Age between 11 years 11 months  and 17 years 11 months\n\n          -  Autism spectrum disorder according to DSM V\n\n          -  ADI > 10\n\n          -  WISC > 70\n\n          -  CARS > 30\n\n        Exclusion Criteria:\n\n          -  Female\n\n          -  presence of genetic and neurological syndromes\n\n          -  changes in drugs or in any intervention during the study"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02007447", 
            "org_study_id": "CAAE 10922213.7.0000.0068"
        }, 
        "intervention": {
            "arm_group_label": "OCYTOCINA - SPRAY NASAL", 
            "description": "The initial sample is divided into two groups (A and B): group A receive oxytocin intranasal for 8 weeks 24UI twice a day (3 applications per nostril 4UI 12/12 hours); group B will receive placebo for 8 weeks", 
            "intervention_name": "OCYTOCINA - SPRAY NASAL", 
            "intervention_type": "Drug", 
            "other_name": [
                "SYNTOCINON - SPRAY NASAL", 
                "OXYTOCIN"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Oxytocin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "autism, oxytocin, autism spectrum disorder, social skills.", 
        "lastchanged_date": "December 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "zip": "05043-903"
                }, 
                "name": "Institute os Psychiatry, Clinical Hospital at S\u00e3o Paulo"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Oxytocin in Adolescents With Autism Spectrum Disorders", 
        "other_outcome": [
            {
                "description": "Evaluation disruptive behavior: Vineland, just the part that assess disruptive behavior", 
                "measure": "Evaluation disruptive behavior: Vineland, just the part that assess disruptive behavior", 
                "safety_issue": "No", 
                "time_frame": "8 WEEKS"
            }, 
            {
                "description": "Multidimensional Student's Life Satisfaction Scale (MSLSS): SCALE OF QUALITY OF LIFE", 
                "measure": "Multidimensional Student's Life Satisfaction Scale (MSLSS)", 
                "safety_issue": "No", 
                "time_frame": "8 WEEKS"
            }
        ], 
        "overall_official": {
            "affiliation": "University of Sao Paulo General Hospital", 
            "last_name": "Helena P. Brentani, PHD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Brazil: National Health Surveillance Agency", 
                "Brazil: National Committee of Ethics in Research", 
                "Brazil: Ethics Committee", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluation of social skills: Matson Evaluation of Social Skills (MESSY): consisting of 62 items divided into six factors that assess social skills such as appropriate social skills, assertiveness inadequate, impulsivity, self-confidence, jealousy withdraw, and other items that do not fit another classification.", 
            "measure": "SOCIAL SKILLS", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "reference": {
            "PMID": "23480321", 
            "citation": "Tachibana M, Kagitani-Shimono K, Mohri I, Yamamoto T, Sanefuji W, Nakamura A, Oishi M, Kimura T, Onaka T, Ozono K, Taniike M. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. J Child Adolesc Psychopharmacol. 2013 Mar;23(2):123-7. doi: 10.1089/cap.2012.0048. Epub 2013 Mar 12."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02007447"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Sao Paulo General Hospital", 
            "investigator_full_name": "Helena Paula Brentani", 
            "investigator_title": "Helena Paula Brentani", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Evaluation of repetitive behavior: Repetitive Behavior Scale (RBS): Consists of 43 items divided into six subscales: stereotyped behavior, self-harm behavior, compulsive behavior, ritualistic behavior, behavior monotonous and restricted behavior. This scale is able to measure the presence and severity of repetitive behaviors as common in individuals on the autism spectrum.", 
            "measure": "REPETITIVE BEHAVIOR", 
            "safety_issue": "No", 
            "time_frame": "8 WEEKS"
        }, 
        "source": "University of Sao Paulo General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Sao Paulo General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}